History & Overview
Annual Report
President's Pages
Center News
Community Affairs
Make a Gift
Cycle for Survival
Fred's Team
Rock & Run on the River
Yankees Universe Fund
Thomas Blake Sr. Memorial Research Fund
Donating Blood & Platelets
Volunteering
Thrift Shop
Park Avenue Potluck CELEBRATIONS
Press Releases
In the News
Information for Journalists
News@MSKCC
Manhattan
New Jersey
Long Island
Westchester
Working at Memorial Sloan-Kettering
Work Sites
College Recruitment
About Nursing
Job Fairs & Career Days
IS Careers
Job Search & Apply Online
Clinical Research Program
Brain Tumor & Central Nervous System
Breast Cancer
Colorectal Cancer
Genitourinary Cancer
Gynecologic Cancer
Head and Neck Cancer
Hematology
Hepatobiliary
Infectious Disease
Integrative Medicine
Leukemia
Lymphoma
Melanoma
Pain Management
Pediatric Cancers
Primary Bone
Psychiatry and Behavioral Sciences
Radiation Sciences
Soft Tissue Sarcoma
Thoracic
Clinical Trials
Disease Management Team
Transplantation
Upper Gastrointestinal
Home
>
Research
>
Memorial Hospital Research
>
Clinical Research Program
>
Thoracic
Clinical Trials
Clicking a link below will scroll the
page down to the relevant section
Lung Cancer
Mesothelioma
Lung Cancer
top
A Phase I/II Study of Cetuximab and Erlotinib in Patients with Lung Adenocarcinoma Who Have Developed Resistance to Erlotinib Alone
Riely, Gregory, MD, PhD
[Protocol 08-055]
A Phase I/II Study of Obatoclax Mesylate (GX15-070MS) Plus Topotecan in Patients with Relapsed Small Cell Lung Carcinoma
Krug, Lee, MD
[Protocol 07-082]
A Phase II Study of Erlotinib and AT-101 in Advanced Non-Small Cell Lung Cancer Patients with
EGFR
-Activating Mutations
Rizvi, Naiyer, MD
[Protocol 09-026]
A Phase II Study of Erlotinib and Chemotherapy for Operable Stage IB-IIIA Non-Small Cell Lung Cancer Patients Who Are Nonsmokers or Light Smokers
Rizvi, Naiyer, MD
[Protocol 07-103]
A Phase II Study of Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung Cancer
Pietanza, M. Catherine, MD
[Protocol 08-065]
A Phase II Trial of Dasatinib in Patients with Lung Adenocarcinoma with Acquired Resistance to Erlotinib or Gefitinib
Miller, Vincent, MD
[Protocol 06-143]
A Phase II Trial of Erlotinib in Patients with Resected, Early-Stage Non-Small Cell Lung Cancer (NSCLC) with Epidermal Growth Factor Receptor Mutations
Azzoli, Christopher, MD
[Protocol 08-152]
A Phase II Trial of Paclitaxel, Pemetrexed, and Bevacizumab in Patients with Untreated, Advanced Non-Small Cell Lung Cancer Using Web-Based Data Collection, Patient Self-Reporting of Adverse Effects, and Automated Response Assessment
Pietanza, M. Catherine, MD
[Protocol 08-109]
A Phase Ib Study of MDX-1106 in Patients with Selected Advanced or Recurrent Malignancies
Wolchok, Jedd, MD, PhD
[Protocol 09-012]
A Phase Ib/IIa Study of AV-951 in Patients with Advanced Non-Small Cell Lung Cancer
Rizvi, Naiyer, MD
[Protocol 08-144]
A Pilot Study of Docetaxel plus Vinorelbine as Adjuvant Chemotherapy for Patients with Resected Non-Small Cell Lung Cancer
Azzoli, Christopher, MD
[Protocol 07-178]
A Pilot Trial Assessing the Safety and Immunogenicity of the GI-4000 Vaccine as Consolidation Therapy after Curative Treatment for Stage I-III Non-Small Cell Lung Cancers with K-ras Mutations
Azzoli, Christopher, MD
[Protocol 07-149]
A Randomized Study Comparing Aflibercept versus Placebo in Patients Treated with Second-Line Docetaxel after Failure of One Platinum-Based Therapy for Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Pietanza, M. Catherine, MD
[Protocol 08-075]
A Study of Deforolimus (MK-8669) in Non-Small Cell Lung Cancer Patients with
KRAS
Mutations
Riely, Gregory, MD, PhD
[Protocol 09-047]
Health Communication in Families
Ostroff, Jamie, PhD
[Protocol 03-088]
Improving Functional Outcomes in Patients with Unilateral Vocal Cord Paralysis: Assessment of Adaptation Using Functional Magnetic Resonance Imaging
Kraus, Dennis, MD
[Protocol 05-036]
Multimodality Treatment for Patients with Resectable Non-Small Cell Lung Cancer (BEACON Study: BEvacizumab And Chemotherapy for Operable NSCLC)
Rizvi, Naiyer, MD
[Protocol 05-052]
Phase II Prospective Trial of Vaccine Responses Against Pneumococcus and Influenza in Adult Cancer Patients Age 65 and Older
Small, Trudy, MD
[Protocol 08-005]
Physical Activity Intervention for Lung Cancer Survivors
Ostroff, Jamie, PhD
[Protocol 08-067]
Quality of Life and Pain Outcomes Following Video-Assisted Thoracic Surgery (VATS) Lobectomy versus Thoracotomy and Lobectomy
Park, Bernard, MD
[Protocol 05-006]
Screening for Depression in Lung Cancer Patients
Passik, Steven, PhD
[Protocol 06-038]
Support Needs and Preferences of Family Caregivers of Lung Cancer Patients
Ostroff, Jamie, PhD
[Protocol 09-104]
The Use of Breathing Synchronized PET/CT Imaging in the Detection and Quantification of FDG Uptake in Lung Nodules
Schoder, Heiko, MD
[Protocol 04-025]
Mesothelioma
top
A Phase III Trial of Oral Suberoylanilide Hydroxamic Acid (L-001079038) in Patients With Advanced Malignant Pleural Mesothelioma Previously Treated With Systemic Chemotherapy
Krug, Lee, MD
[Protocol 05-095]
Phase II Study of CBP501, Pemetrexed, and Cisplatin in Chemotherapy-Naïve Patients with Malignant Pleural Mesothelioma
Krug, Lee, MD
[Protocol 08-082]
Phase II Toxicity Study Using Chemotherapy Followed By Intensity Modulated Radiation Therapy to the Pleura in Patients with Locally Advanced Unresectable Malignant Pleural Mesothelioma
Rosenzweig, Kenneth, MD
[Protocol 08-053]
Site Map
|
Index
Legal Disclaimer
|
Privacy Practices
|
Public Notices
©2009 Memorial Sloan-Kettering Cancer Center. 212-639-2000
1275 York Avenue New York, NY 10065.
PublicAffairs@mskcc.org